racemetirosine has been researched along with Cancer of Lung in 6 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe 3 cases of malignant pheochromocytoma with multiple metastases which were treated with cyclophosphamide, vincristine and dacarbazine (CVD) combination chemotherapy and alpha-methyl-p-tyrosine." | 7.70 | Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia. ( Okuda, Y; Tada, K; Yamashita, K, 1998) |
| "We describe 3 cases of malignant pheochromocytoma with multiple metastases which were treated with cyclophosphamide, vincristine and dacarbazine (CVD) combination chemotherapy and alpha-methyl-p-tyrosine." | 3.70 | Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia. ( Okuda, Y; Tada, K; Yamashita, K, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, K | 3 |
| Kaira, K | 4 |
| Higuchi, T | 2 |
| Hisada, T | 2 |
| Yokobori, T | 1 |
| Oyama, T | 1 |
| Asao, T | 1 |
| Tsushima, Y | 1 |
| Shirabe, K | 1 |
| Oriuchi, N | 3 |
| Ishikita, T | 1 |
| Imai, H | 1 |
| Yanagitani, N | 3 |
| Sunaga, N | 3 |
| Ishizuka, T | 3 |
| Kanai, Y | 2 |
| Endou, H | 1 |
| Nakajima, T | 1 |
| Endo, K | 3 |
| Mori, M | 3 |
| Tominaga, H | 1 |
| Serri, O | 1 |
| Comtois, R | 1 |
| Bettez, P | 1 |
| Dubuc, G | 1 |
| Buu, NT | 1 |
| Kuchel, O | 1 |
| Tada, K | 1 |
| Okuda, Y | 1 |
| Yamashita, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Correlation of Angiogenesis With 18F-FMT and 18F-FDG Uptake in Non-Small Cell Lung Cancer[NCT00671242] | 0 participants | Observational | Completed | ||||
| [NCT00464282] | 0 participants | Observational | Completed | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for racemetirosine and Cancer of Lung
| Article | Year |
|---|---|
Relationship Between Tumor Immune Markers and Fluorine-18-α-Methyltyrosine ([
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Analysis of Variance; B7-H1 Antigen; Biomarker | 2020 |
Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Antigens, CD34; Carcinoma, Lar | 2009 |
18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Analysis of Variance; Carcinom | 2009 |
Assessment of therapy response in lung cancer with ¹⁸F-α-methyl tyrosine PET.
Topics: Aged; Aged, 80 and over; alpha-Methyltyrosine; Antineoplastic Combined Chemotherapy Protocols; Combi | 2010 |
Reduction in the size of a pheochromocytoma pulmonary metastasis by metyrosine therapy.
Topics: Adrenal Gland Neoplasms; Aged; alpha-Methyltyrosine; Female; Humans; Lung Neoplasms; Methyltyrosines | 1984 |
Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia.
Topics: Adrenal Gland Neoplasms; Adult; alpha-Methyltyrosine; Antineoplastic Combined Chemotherapy Protocols | 1998 |